160 related articles for article (PubMed ID: 8532551)
1. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
Mahon SM
Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
[TBL] [Abstract][Full Text] [Related]
2. Mailings timed to patients' appointments: a controlled trial of fecal occult blood test cards.
Goldberg D; Schiff GD; McNutt R; Furumoto-Dawson A; Hammerman M; Hoffman A
Am J Prev Med; 2004 Jun; 26(5):431-5. PubMed ID: 15165660
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
[TBL] [Abstract][Full Text] [Related]
4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
5. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
9. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood testing: a false sense of security?
Schnell T; Aranha GV; Sontag SJ; Tode R; Reid S; Chejfec G; Karpf J; Levine G
Surgery; 1994 Oct; 116(4):798-802; discussion 802-3. PubMed ID: 7940181
[TBL] [Abstract][Full Text] [Related]
11. Fecal occult blood testing for colorectal cancer screening: use the finger.
Burke CA; Tadikonda L; Machicao V
Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
[TBL] [Abstract][Full Text] [Related]
12. An audit of the utility of in-patient fecal occult blood testing.
Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
15. Digital fecal occult blood testing in the ambulatory urology clinic.
Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
17. Digital rectal fecal occult blood screening during gynecologic examination.
Willis FL; Fanning J
Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
[TBL] [Abstract][Full Text] [Related]
18. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district.
Grazzini G; Ventura L; Zappa M; Ciatto S; Confortini M; Rapi S; Rubeca T; Visioli CB; Halloran SP
Gut; 2010 Nov; 59(11):1511-5. PubMed ID: 20603498
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count?
Eisner MS; Lewis JH
Arch Intern Med; 1991 Nov; 151(11):2180-4. PubMed ID: 1953220
[TBL] [Abstract][Full Text] [Related]
20. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]